Literature DB >> 17805515

Adaptation to excess acetylcholine by downregulation of adrenoceptors and muscarinic receptors in lungs of acetylcholinesterase knockout mice.

Jaromir Myslivecek1, Ellen G Duysen, Oksana Lockridge.   

Abstract

The acetylcholinesterase knockout mouse has elevated acetylcholine levels due to the complete absence of acetylcholinesterase. Our goal was to determine the adaptive changes in lung receptors that allow these animals to tolerate excess neurotransmitter. The hypothesis was tested that not only muscarinic receptors but also alpha(1)-adrenoceptors and beta-adrenoceptors are downregulated, thus maintaining a proper balance of receptors and accounting for lung function in these animals. The quantity of alpha(1A), alpha(1B), alpha(1D), beta(1), and beta(2)-adrenoceptors and muscarinic receptors was determined by binding of radioligands. G-protein coupling was assessed using pseudo-competition with agonists. Phospholipase C activity was measured by an enzymatic assay. Cyclic AMP (cAMP) content was measured by immunoassay. Muscarinic receptors were decreased to 50%, alpha(1)-adrenoceptors to 23%, and beta-adrenoceptors to about 50% of control. Changes were subtype specific, as alpha(1A), alpha(1B), and beta(2)-adrenoceptors, but not alpha(1D)-adrenoceptor, were decreased. In contrast, receptor signaling into the cell as measured by coupling to G proteins, cAMP content, and PI-phospholipase C activity was the same as in control. This shows that the nearly normal lung function of these animals was explained by maintenance of a correct balance of adrenoceptors and muscarinic receptors. In conclusion, knockout mice have adapted to high concentrations of acetylcholine by downregulating receptors that bind acetylcholine, as well as by downregulating receptors that oppose the action of muscarinic receptors. Tolerance to excess acetylcholine is achieved by reducing the levels of muscarinic receptors and adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805515     DOI: 10.1007/s00210-007-0184-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

Review 1.  Intraneuronal trafficking of G-protein-coupled receptors in vivo.

Authors:  Véronique Bernard; Marion Décossas; Isabel Liste; Bertrand Bloch
Journal:  Trends Neurosci       Date:  2006-01-27       Impact factor: 13.837

Review 2.  Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors.

Authors:  E F Grady; S K Böhm; N W Bunnett
Journal:  Am J Physiol       Date:  1997-09

3.  Muscarinic receptors are affected by corticotropin-releasing hormone and c-fos gene disruptions: is there a mutual connection to adrenoceptors?

Authors:  Martina Nováková; Jan Benes; Lucia Kubovcáková; Richard Kvetnansky; Jaromír Myslivecek
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis.

Authors:  Gurpreet K Dhami; Stephen S G Ferguson
Journal:  Pharmacol Ther       Date:  2006-03-06       Impact factor: 12.310

5.  Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.

Authors:  Z P Yang; W D Dettbarn
Journal:  Biochem Pharmacol       Date:  1998-05-01       Impact factor: 5.858

6.  Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase.

Authors:  W Xie; J A Stribley; A Chatonnet; P J Wilder; A Rizzino; R D McComb; P Taylor; S H Hinrichs; O Lockridge
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

7.  Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation.

Authors:  Wei Liang; Peter H Fishman
Journal:  J Biol Chem       Date:  2004-08-25       Impact factor: 5.157

8.  Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice.

Authors:  Laura A Volpicelli-Daley; Ellen G Duysen; Oksana Lockridge; Allan I Levey
Journal:  Ann Neurol       Date:  2003-06       Impact factor: 10.422

Review 9.  Adrenoceptors in airway smooth muscle.

Authors:  R G Goldie; J W Paterson; K M Lulich
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

10.  Dramatic depletion of cell surface m2 muscarinic receptor due to limited delivery from intracytoplasmic stores in neurons of acetylcholinesterase-deficient mice.

Authors:  Véronique Bernard; Corinne Brana; Isabel Liste; Oksana Lockridge; Bertrand Bloch
Journal:  Mol Cell Neurosci       Date:  2003-05       Impact factor: 4.314

View more
  4 in total

1.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

2.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

3.  Beta3 adrenoceptors substitute the role of M(2) muscarinic receptor in coping with cold stress in the heart: evidence from M(2)KO mice.

Authors:  Jan Benes; Martina Novakova; Jana Rotkova; Vladimir Farar; Richard Kvetnansky; Vladimir Riljak; Jaromir Myslivecek
Journal:  Cell Mol Neurobiol       Date:  2012-01-06       Impact factor: 5.046

4.  Developmental adaptation of central nervous system to extremely high acetylcholine levels.

Authors:  Vladimir Farar; Anna Hrabovska; Eric Krejci; Jaromir Myslivecek
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.